Stay updated on Datopotamab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Datopotamab in Lung Cancer Clinical Trial page.

Latest updates to the Datopotamab in Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the site and removed an outdated government funding status notice; these are minor UI/maintenance updates and do not affect core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, with guidance to cc.nih.gov and opm.gov for updates. Revision: v3.4.1 was added, replacing the previous v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedAdds a Show glossary toggle and new metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted) along with a Revision: v3.4.0 label; removes the older labels Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the page, while references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed; this appears to be an administrative update, and to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2 and last update timestamps were added (2025-11-26 and 2025-11-24), along with the estimated primary completion date of 2028-04. These are metadata changes and do not modify the study design, eligibility criteria, locations, interventions, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Datopotamab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Datopotamab in Lung Cancer Clinical Trial page.